BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors
April 26, 2024 17:09 ET
|
BrightSpring Health Services, Inc.
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health...
Vertex, Inc. Announces Closing of Upsized Offering of $345 Million Convertible Senior Notes
April 26, 2024 17:09 ET
|
Vertex Inc.
KING OF PRUSSIA, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex”), a leading global provider of indirect tax solutions, today announced the closing of its private...
Fairfax Announces Conference Call
April 26, 2024 17:02 ET
|
Fairfax Financial Holdings Limited
TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) will hold a conference call at 8:30 a.m. Eastern Time on Friday, May 3, 2024 to discuss its 2024...
DOCS Class Action Alert: Robbins LLP Reminds Doximity, Inc. Shareholders of the Lead Plaintiff Deadline in the Class Action Lawsuit
April 26, 2024 17:00 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Doximity, Inc. (DOCS) Misled Investors Regarding Demand for its Products and Services
Firm Capital Apartment REIT Reports Q4/2023 and 2023 Results and Provides Strategic Review Update
April 26, 2024 17:00 ET
|
Firm Capital Apartment Real Estate Investment Trust
All figures in $USD unless otherwise noted. TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Firm Capital Apartment Real Estate Investment Trust (“the “Trust”), (TSXV: FCA.U), (TSXV: FCA.UN) is...
Revised Announcement Regarding Application for Management Cease Trade Order
April 26, 2024 17:00 ET
|
Decklar Resources Inc.
CALGARY, Alberta, April 26, 2024 (GLOBE NEWSWIRE) -- Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the “Company” or “Decklar”) announces herewith a revised default announcement from...
Robbins LLP Reminds Stockholders of CKPT to Contact the Law Firm for Information About the Checkpoint Therapeutics, Inc. Class Action Lawsuit
April 26, 2024 16:56 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Checkpoint Therapeutics, Inc. Overstated the Prospects of its Lead Product Candidate, Cosibelimab
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 26, 2024 16:51 ET
|
Lyra Therapeutics
WATERTOWN, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the “Company” or “Lyra”), a clinical-stage biotech developing long-acting, anti-inflammatory sinonasal...
Society Pass Incorporated Announces 1-for-15 Reverse Split
April 26, 2024 16:50 ET
|
Society Pass Incorporated
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Society Pass Inc. (Nasdaq: SOPA) (“SOPA” or the “Company”), Southeast Asia’s (SEA) next generation, e-commerce ecosystem, today announced that the board...
Robbins LLP Reminds Investors of Bluebird Bio, Inc. to Contact the Law Firm for Information About the Class Action Against BLUE
April 26, 2024 16:45 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug